Severely diminished response to vitamin K-treatment for self-inflicted warfarin intoxication in a patient genotyped as CYP2C9*3*3.
Bäckström
Tobias
T
Barkman
Gunilla
G
Lindh
Jonatan D
JD
Eliasson
Erik
E
D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics* / Q000633:toxicity*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D003029:Coagulants / Q000008:administration & dosage*; D065729:Cytochrome P-450 CYP2C9; D005260:Female; D005838:Genotype; D006801:Humans; D011041:Poisoning / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome; D014812:Vitamin K / Q000008:administration & dosage*; D014859:Warfarin / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics* / Q000633:toxicity*
D000925:Anticoagulants; D003029:Coagulants; D014812:Vitamin K; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases